Target intelligence / Profile preview

Actin gamma 1 pseudogene 11 (ACTG1P11)

Target: ACTG1P11
Molecular classification: Other (pseudogene)

Overview

Actin gamma 1 pseudogene 11 (ACTG1P11) is designated as a pseudogene and does not encode a functional protein product. Pseudogenes are typically regarded as defunct relatives of genes—they bear sequence similarity to known genes (in this case, the functional actin gamma 1 gene), but have lost protein-coding ability due to mutations, insertions, or deletions. As a result, ACTG1P11 does not produce actin or any related active molecule. There is no evidence in scientific databases that ACTG1P11 serves any defined physiological, therapeutic, or diagnostic function, nor is it implicated in disease or drug action pathways[5].

Other names: Actin gamma 1 pseudogene 11ACTG1P11

Beyond the preview

Go deeper on Actin gamma 1 pseudogene 11 (ACTG1P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene 11 (ACTG1P11).

Explore the full profile